JP2007516211A5 - - Google Patents

Download PDF

Info

Publication number
JP2007516211A5
JP2007516211A5 JP2006520478A JP2006520478A JP2007516211A5 JP 2007516211 A5 JP2007516211 A5 JP 2007516211A5 JP 2006520478 A JP2006520478 A JP 2006520478A JP 2006520478 A JP2006520478 A JP 2006520478A JP 2007516211 A5 JP2007516211 A5 JP 2007516211A5
Authority
JP
Japan
Prior art keywords
amino
ethyl
hydroxy
methylsulfonyl
phenylethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006520478A
Other languages
English (en)
Japanese (ja)
Other versions
JP4618250B2 (ja
JP2007516211A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2004/019495 external-priority patent/WO2005061433A2/en
Publication of JP2007516211A publication Critical patent/JP2007516211A/ja
Publication of JP2007516211A5 publication Critical patent/JP2007516211A5/ja
Application granted granted Critical
Publication of JP4618250B2 publication Critical patent/JP4618250B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2006520478A 2003-12-23 2004-12-20 アミノアルコール誘導体 Expired - Fee Related JP4618250B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003907111A AU2003907111A0 (en) 2003-12-23 Aminoalcohol Derivatives
PCT/JP2004/019495 WO2005061433A2 (en) 2003-12-23 2004-12-20 Aminoalcohol derivatives

Publications (3)

Publication Number Publication Date
JP2007516211A JP2007516211A (ja) 2007-06-21
JP2007516211A5 true JP2007516211A5 (US06534493-20030318-C00288.png) 2008-02-14
JP4618250B2 JP4618250B2 (ja) 2011-01-26

Family

ID=34658494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006520478A Expired - Fee Related JP4618250B2 (ja) 2003-12-23 2004-12-20 アミノアルコール誘導体

Country Status (10)

Country Link
US (1) US7417060B2 (US06534493-20030318-C00288.png)
EP (1) EP1697301A2 (US06534493-20030318-C00288.png)
JP (1) JP4618250B2 (US06534493-20030318-C00288.png)
KR (1) KR101071748B1 (US06534493-20030318-C00288.png)
CN (1) CN100582088C (US06534493-20030318-C00288.png)
AR (1) AR047351A1 (US06534493-20030318-C00288.png)
CA (1) CA2551167C (US06534493-20030318-C00288.png)
MX (1) MXPA06007173A (US06534493-20030318-C00288.png)
TW (1) TW200526551A (US06534493-20030318-C00288.png)
WO (1) WO2005061433A2 (US06534493-20030318-C00288.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0311788A (pt) * 2002-06-27 2005-03-15 Fujisawa Pharmaceutical Co Composto derivado aminoalcoólico, processo para sua preparação, composição farmacêutica, compreendendo o mesmo, seu uso e método de tratamento
EP1593666B1 (en) 2003-02-14 2008-07-02 Kissei Pharmaceutical Co., Ltd. Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
EP1679304A4 (en) 2003-10-24 2006-11-15 Kissei Pharmaceutical AMINO ALCOHOL DERIVATIVE, MEDICAL COMPOSITION CONTAINING THEREOF AND ITS USE
KR101071748B1 (ko) 2003-12-23 2011-10-11 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체
WO2006022237A1 (ja) * 2004-08-24 2006-03-02 Kissei Pharmaceutical Co., Ltd. 脂肪肝の予防または治療剤
JP4893620B2 (ja) * 2004-09-21 2012-03-07 アステラス製薬株式会社 アミノアルコール誘導体
CA2602609A1 (en) * 2005-03-16 2006-09-21 Junichi Yokotani Novel anthranilic acid derivative or salt thereof
KR100901664B1 (ko) 2007-08-06 2009-06-09 주식회사 오스코텍 β-아미노알콜 유도체, 이의 제조방법 및 이를유효성분으로 함유하는 TNF-α 매개성 질환의 예방 및치료용 약학적 조성물
PT3365321T (pt) * 2015-10-23 2024-01-12 B3Ar Therapeutics Inc Zwiterião de solabegron e suas utilizações

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718638A1 (de) * 1987-06-04 1988-12-22 Thomae Gmbh Dr K Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
MX9708621A (es) * 1995-05-10 1998-02-28 Pfizer AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
AU2001292161A1 (en) * 2000-10-20 2002-04-29 Pfizer Products Inc. Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
EP1448561B1 (en) * 2001-11-20 2008-02-20 Eli Lilly And Company Beta 3 adrenergic agonists
DOP2003000587A (es) * 2002-02-27 2003-08-30 Pfizer Prod Inc AGONISTAS DEL RECEPTOR ß3-ADRENERGICO
MXPA04008298A (es) * 2002-02-27 2004-11-26 Pfizer Prod Inc Procesos e intermedios utiles en la preparacion de agonistas de receptor beta-3 adrenergico.
CA2479065A1 (en) * 2002-03-14 2003-09-18 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
BR0311788A (pt) * 2002-06-27 2005-03-15 Fujisawa Pharmaceutical Co Composto derivado aminoalcoólico, processo para sua preparação, composição farmacêutica, compreendendo o mesmo, seu uso e método de tratamento
AU2002952839A0 (en) * 2002-11-21 2002-12-05 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
EP1593666B1 (en) * 2003-02-14 2008-07-02 Kissei Pharmaceutical Co., Ltd. Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
KR101071748B1 (ko) 2003-12-23 2011-10-11 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체

Similar Documents

Publication Publication Date Title
RU2214997C2 (ru) Производные адамантана, способ их получения, фармацевтическая композиция и способ получения фармацевтической композиции
RU2202344C2 (ru) Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции
RU2020108515A (ru) Соединения и способы целевого расщепления андрогенного рецептора
RU2004134564A (ru) Химические соединения
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
JP2004532209A5 (US06534493-20030318-C00288.png)
JP2008540554A5 (US06534493-20030318-C00288.png)
AR045317A1 (es) Forma cristalina de agonista dl receptor adrenergico b2
PE20040775A1 (es) DERIVADOS DE INDOL COMO AGONISTAS DE ADRENORECEPTORES ß2
PE20110285A1 (es) Derivados de sulfonamidofenil propionamida como ligandos del receptor vaniloide del subtipo 1
RU2006146678A (ru) N-(2-бензил)-2-фенилбутанамиды в качестве модуляторов рецептора андрогена
JP2016503786A5 (US06534493-20030318-C00288.png)
CA2660529A1 (en) Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
RU2283835C3 (ru) Производные гетероциклических соединений и лекарственные средства
JP2005522438A5 (US06534493-20030318-C00288.png)
RU2003103848A (ru) Пиримидиновые производные
PE20060693A1 (es) Nuevos derivados de trifluorometansulfonanilida oxamida eter
JP2004518723A5 (US06534493-20030318-C00288.png)
DK1735278T3 (da) Histamin H3-receptormidler, fremstilling og terapeutiske anvendelser
KR970703333A (ko) 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists)
JP2011529037A5 (US06534493-20030318-C00288.png)
JP2002520316A5 (US06534493-20030318-C00288.png)
JP2009504793A5 (US06534493-20030318-C00288.png)
JP2005511547A5 (US06534493-20030318-C00288.png)
JP2022043059A5 (US06534493-20030318-C00288.png)